From Cornea to Macula: The Potential Role of Dry Eye–Related Ocular Surface Inflammation in Macular Degeneration

Huini Zhang

doi:10.62051/ijphmr.v6n4.19

Authors

Huini Zhang

DOI:

https://doi.org/10.62051/ijphmr.v6n4.19

Keywords:

Dry eyes, Ocular surface inflammation, Macular degeneration, Age-related macular degeneration

Abstract

Dry eye is a chronic inflammatory disease of the ocular surface caused by shortened tear film rupture time and high osmotic pressure. Macular degeneration, especially AMD, is one of the main causes of blindness worldwide, traditionally believed to be mainly caused by RPE aging, oxidative damage, and choroidal circulation disorders. In recent years, epidemiological and basic research has also suggested that chronic inflammatory reactions on the ocular surface can participate in the occurrence and development of macular degeneration through common inflammatory pathways, oxidative stress amplification effects, and immune regulation disorders. In summary, this article mainly elaborates on the inflammatory pathway from the cornea to the macular area and the possible ways in which inflammatory mediators extend from the ocular surface to the posterior part of the eye. It also provides new ideas for the involvement of ocular surface inflammation caused by dry eye in the treatment of AMD, hoping to help achieve a multi site integrated diagnosis and treatment model for the eye.

References

[1] Magnin S, Figueiredo O D C E, Vermeirsch S, et al. Ultra-high-resolution imaging of acute macular neuroretinopathy: a case report [J]. American Journal of Ophthalmology Case Reports, 2026, 42 102564-102564. DOI:10.1016/J.AJOC.2026.102564.

[2] Alshaikhsalama A, Thompson K, Hashim H, et al. Analyzing the association between age-related macular degeneration, retinal vascular occlusions, and dementia. [J]. European journal of ophthalmology, 2026, 11206721261438587. DOI:10.1177/11206721261438587.

[3] J G M, Shweta J, Akhila S, et al. Macular Telangiectasia Type 2 With Bidirectional Neovascular Network [J]. RETINAL Cases & Brief Reports, 2026, DOI:10.1097/ICB.0000000000001919.

[4] Ninan J, Jay C, Umesh B C, et al. Large and medium choroidal vessel remodelling in progressive age-related macular degeneration and polypoidal choroidal vasculopathy [J]. RETINAL Cases & Brief Reports, 2026, DOI:10.1097/ICB.0000000000001925.

[5] Christina M, Aikaterini G, Asli P, et al. Acute Macular Neuroretinopathy in a 27-year-old male patient following impending central retinal vein occlusion [J]. RETINAL Cases & Brief Reports, 2026, DOI:10.1097/ICB.0000000000001921.

[6] Li S, Xu Y, Xu Y, et al. Remote Management of Patients With Diabetic Macular Edema Receiving Long-Term Intravitreal Anti-Vascular Endothelial Growth Factor Therapy (RE-SHINE Study): Protocol for a Real-World Study. [J]. JMIR research protocols, 2026, 15 e85764. DOI:10.2196/85764.

[7] Krishnan R A, Famiyeh M I, Ahmad A, et al. Macular and retinal manifestations following COVID-19 vaccinations: a 2025 update systematic review and meta-analysis [J]. Eye, 2026, (prepublish): 1-9. DOI:10.1038/S41433-026-04324-4.

[8] Mehta H. Social deprivation in neovascular age-related macular degeneration: when equal treatment does not deliver equal vision [J]. Eye, 2026, (prepublish): 1-2. DOI:10.1038/S41433-026-04423-2.

[9] Bagewadi S, Parameswaran S, Sethuraman S, et al. Hyaluronic acid-poly (vinyl alcohol) composite hydrogels with self-assembled peptide nanofibers as Bruch's membrane mimics for age-related macular degeneration treatment. [J]. International journal of biological macromolecules, 2026, 151748. DOI:10.1016/J.IJBIOMAC.2026.151748.

[10] Shi N X, Zhang Y Q, Ju J C, et al. Efficacy of Anti-VEGF therapy for different OCT Patterns in diabetic macular edema and the correlation between ellipsoid zone integrity and visual acuity. [J]. Scientific reports, 2026, DOI:10.1038/S41598-026-47416-7.